Larry Blandford, PharmD—Column Editor

Pharma Insights

How Development of Gene Therapies Impact Decisions on Their Place in Therapy

11/18/2019

Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...

Gene...

11/18/2019

Journal of Clinical Pathways

Pharma Insights

The Challenge With Today’s Value Assessments: Not Evolving With the Evidence

04/16/2019

Larry Blandford , PharmD;

The methodologies employed within value assessments, especially by the Institute for Clinical and Economic Review (ICER), primarily measure value through quality-adjusted life-years (QALYs). While also the common...

The...

04/16/2019

Journal of Clinical Pathways

Pharma Insights

What Does New Payer Research on Expected Biosimilar Management Mean to Others?

05/12/2017

Larry Blandford , PharmD;

Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...

...

05/12/2017

Journal of Clinical Pathways

Pharma Insights

When Medication Price Deflates Perception of Therapeutic Effect

04/11/2016

Larry Blandford , PharmD;

Stephen C. Carter , BSc;

Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...

...

04/11/2016

Journal of Clinical Pathways